ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 281617 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 281617; 2) Community: the network communities that were significantly associated with the response to NSC 281617; 3) Molecule: the relationships between components within communities and NSC 281617; 4) MDR: the compounds that were significantly associated with the NSC 281617.

NSC Compound Enrichment Correlation
NSC 30706 2,5-Di(ethyleneimino)-1,4-benzoquinone 0.0202245331784479 0.52868151
NSC 381866 BAFILOMYCIN DERIV. 0.0202245331784479 0.084759698
NSC 641009 Tellurium, trichloro[1,2-hexanedioato(2-)-O,O']-, ammonium 0.0202245331784479 0.17276568
NSC 676788 Olean-12-en-28-oic acid, 3-.beta.-(6-methyl-.beta.-D-glucopyranuronosyloxy)-, [2-O-[4-O-(.beta.-D-xylopyranosyl)-6-deoxy- .beta.-D-gulopyranosyl]-.beta.-L-arabinopyranosyl] ester 0.0202245331784479 -0.32342493
NSC 677949 Quinoline-5,8-dione, 7-[(3-hydroxy-3-phenyl-2-propyl)amino]- 0.0202245331784479 0.13330774
NSC 681644 Camptothecin Derivative 0.0202245331784479 0.58800922
NSC 683557 Camptothecin Derivative 0.0202245331784479 0.49231641
NSC 732661 6-(3-Chloropropyl)-5,6-dihydro-5,11-dioxo-11H-indeno[1,2-c]i soquinoline 0.0202245331784479 0.41396918
NSC 758450 Mitoxantrone hydrochloride (USAN) 0.0202245331784479 0.61225143
NSC 763198 Null 0.0202245331784479 0.042897792
Total:50  Current:19    [First] [Prev] [Next] [Last]